Apr 26 |
Why Indivior PLC (LON:INDV) Looks Like A Quality Company
|
Apr 25 |
Indivior PLC (INDV) Q1 Earnings and Revenues Lag Estimates
|
Apr 25 |
UPDATE 1-UK-listed drugmaker Indivior seeks shareholder nod for US listing
|
Apr 25 |
Indivior Confirms Plan to Switch Listing From London to New York
|
Apr 25 |
Indivior Announces Q1 2024 Financial Results
|
Apr 4 |
Indivior (INDV) Surges 5.6%: Is This an Indication of Further Gains?
|
Mar 19 |
Indivior PLC (INDV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
|
Mar 11 |
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
|
Mar 7 |
Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia
|
Mar 6 |
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
|